Related Experiment Video
Updated: Jun 6, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Putative tissue markers in prostate cancer*
Urologia
|November 19, 2010
Summary
Identifying reliable prostate cancer markers requires a biological rationale, validated association with disease outcomes, and independent predictive value in multivariate analysis for clinical use.
Area of Science:
- Oncology
- Biomarker Discovery
- Prostate Cancer Research
Background:
- Numerous potential prostate cancer biomarkers exist in various biological samples.
- These markers show variable effectiveness in detecting cancer and predicting its progression.
- Rigorous criteria are needed to validate these markers for clinical application.
Purpose of the Study:
- To outline the essential criteria for evaluating prostate cancer markers.
- To emphasize the importance of biological rationale and clinical validation for diagnostic and prognostic markers.
Main Methods:
- Review of existing literature on prostate cancer markers.
- Analysis of criteria for marker validation in clinical settings.
- Emphasis on statistical validation including multivariate analysis.
Main Results:
- Prostate cancer markers must have a clear biological or therapeutic rationale.
- Marker association strength with disease outcome needs thorough assessment.
- Independent predictive capability in multivariate analysis is crucial.
Conclusions:
- Validated prostate cancer markers require a strong scientific basis and proven clinical utility.
- Meeting these criteria is essential for advancing markers to large-scale clinical evaluation.
